Prosecution Insights
Last updated: May 29, 2026

Nevro Corp.

5 pending office actions • 2 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (80%)
0
Easy (0%)
1
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only4 (80%)
No statute on record1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUTCHLER, CHRISTOPHER JOHN 1 50.0% +18.9%
TEIXEIRA MOFFAT, JONATHAN CHARLES 1 68.1% +10.4%
ALTER MORSCHAUSER, ALYSSA MARGO 1 76.8% +15.9%
BAIG, RUMAISA RASHID 1 21.6% +30.9%
SCHAETZLE, KENNEDY 1 84.1% +9.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17991810 THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS BAIG, RUMAISA RASHID 19d overdue

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18352846 SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION ALTER MORSCHAUSER, ALYSSA MARGO 184d overdue
17991810 THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS BAIG, RUMAISA RASHID 19d overdue
18531474 SYSTEMS AND METHODS FOR PRODUCING ASYNCHRONOUS NEURAL RESPONSES TO TREAT PAIN AND/OR OTHER PATIENT CONDITIONS TEIXEIRA MOFFAT, JONATHAN CHARLES 6d
18664524 SYSTEMS AND METHODS FOR TREATING MOTOR DYSFUNCTION, INCLUDING BY SELECTIVELY ACTIVATING AND/OR SUPPRESSING MOTOR NEURONS AND/OR MOTOR RESPONSES MUTCHLER, CHRISTOPHER JOHN 75d

Top Art Units

Art UnitApps
3796 4
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18664524 SYSTEMS AND METHODS FOR TREATING MOTOR DYSFUNCTION, INCLUDING BY SELECTIVELY ACTIVATING AND/OR SUPPRESSING MOTOR NEURONS AND/OR MOTOR RESPONSES MUTCHLER, CHRISTOPHER JOHN 3796 §103 Non-Final OA 75d Pending May 15, 2024
18531474 SYSTEMS AND METHODS FOR PRODUCING ASYNCHRONOUS NEURAL RESPONSES TO TREAT PAIN AND/OR OTHER PATIENT CONDITIONS TEIXEIRA MOFFAT, JONATHAN CHARLES 3792 §103 Non-Final OA 6d Pending Dec 06, 2023
18352846 SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION ALTER MORSCHAUSER, ALYSSA MARGO 3796 §103 Non-Final OA 184d overdue Pending Jul 14, 2023
17991810 THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS BAIG, RUMAISA RASHID 3796 §103 Non-Final OA 19d overdue Pending Nov 21, 2022
17173725 MOLDED HEADERS FOR IMPLANTABLE SIGNAL GENERATORS, AND ASSOCIATED SYSTEMS AND METHODS SCHAETZLE, KENNEDY 3796 Other Final Rejection 5d overdue Pending Feb 11, 2021

Managing Nevro Corp.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month